Table 5.
A,B. Outcomes
| Treatment | Time point | n | n | Mean (SD) | |
|---|---|---|---|---|---|
| A. Neonatal endpoints | |||||
| Apgar score at 1 min | Retosiban | Birth | 30 | 30 | 8.3 (0.88) |
| PBO | Birth | 34 | 34 | 8.2 (0.77) | |
| Apgar score at 5 min | Retosiban | Birth | 30 | 30 | 9 (0.53) |
| PBO | Birth | 34 | 34 | 8.9 (0.34) | |
| Length (cm) | Retosiban | Birth | 30 | 28 | 47.8 (2.78) |
| PBO | Birth | 34 | 34 | 47.8 (3.39) | |
| Retosiban | Follow-up | 30 | 22 | 50.6 (2.89) | |
| PBO | Follow-up | 34 | 29 | 51.3 (3.3) | |
| Neonatal weight (g) | Retosiban | Birth | 30 | 30 | 3099 (512.6) |
| PBO | Birth | 34 | 34 | 2940 (585.0) | |
| Retosiban | Follow-up | 30 | 22 | 3427 (635.5) | |
| PBO | Follow-up | 34 | 30 | 3602 (659.5) | |
| Neonatal head circumference (cm) | Retosiban | Birth | 30 | 27 | 33.3 (1.78) |
| PBO | Birth | 34 | 34 | 33.1 (1.63) | |
| Retosiban | Follow-up | 30 | 21 | 35.1 (1.75) | |
| PBO | Follow-up | 34 | 27 | 35.2 (1.77) | |
| Time to follow-up (days) | Retosiban | Follow-up | 30 | 22 | 18.4 (15.67) |
| PBO | Follow-up | 34 | 31 | 25.1 (20.45) | |
| B. Gross development reported at follow-up | |||||
| Treatment | n | Normal | Abnormal | Not reported | |
| Gross development | Retosiban | 30 | 22 | 0 | 8 |
| PBO | 34 | 30 | 1 | 3 | |